Patents Assigned to Illumina
  • Patent number: 12217829
    Abstract: The technology disclosed relates to determining pathogenicity of variants. In particular, the technology disclosed relates to generating amino acid-wise distance channels for a plurality of amino acids in a protein. Each of the amino acid-wise distance channels has voxel-wise distance values for voxels in a plurality of voxels. A tensor includes the amino acid-wise distance channels and at least an alternative allele of the protein expressed by a variant. A deep convolutional neural network determines a pathogenicity of the variant based at least in part on processing the tensor. The technology disclosed further augments the tensor with supplemental information like a reference allele of the protein, evolutionary conservation data about the protein, annotation data about the protein, and structure confidence data about the protein.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: February 4, 2025
    Assignee: Illumina, Inc.
    Inventors: Tobias Hamp, Hong Gao, Kai-How Farh
  • Patent number: 12217831
    Abstract: The technology disclosed assigns quality scores to bases called by a neural network-based base caller by (i) quantizing classification scores of predicted base calls produced by the neural network-based base caller in response to processing training data during training, (ii) selecting a set of quantized classification scores, (iii) for each quantized classification score in the set, determining a base calling error rate by comparing its predicted base calls to corresponding ground truth base calls, (iv) determining a fit between the quantized classification scores and their base calling error rates, and (v) correlating the quality scores to the quantized classification scores based on the fit.
    Type: Grant
    Filed: April 5, 2023
    Date of Patent: February 4, 2025
    Assignee: Illumina, Inc.
    Inventors: Kishore Jaganathan, John Randall Gobbel, Amirali Kia
  • Patent number: 12217832
    Abstract: The technology disclosed directly operates on sequencing data and derives its own feature filters. It processes a plurality of aligned reads that span a target base position. It combines elegant encoding of the reads with a lightweight analysis to produce good recall and precision using lightweight hardware. For instance, one million training examples of target base variant sites with 50 to 100 reads each can be trained on a single GPU card in less than 10 hours with good recall and precision. A single GPU card is desirable because it a computer with a single GPU is inexpensive, almost universally within reach for users looking at genetic data. It is readily available on could-based platforms.
    Type: Grant
    Filed: May 9, 2023
    Date of Patent: February 4, 2025
    Assignees: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Ole Schulz-Trieglaff, Anthony James Cox, Kai-How Farh
  • Patent number: 12209266
    Abstract: Disclosed herein include methods of generating a single stranded deoxyribonucleic acid (ssDNA) scaffold comprising nucleotides with modified bases using a recombinant terminal deoxynucleotidyl transferase (TdT). The recombinant TdT can comprise an amino acid sequence that is at least 80% identical to a Bos taurus TdT, or a fragment thereof, and for example comprise one or more amino acid substitution mutations at one or more positions functionally equivalent to Glu191, Lys193, Glu194, Asp242, Lys287, Phe296, Met299, Thr342, and His420 in the Bos taurus TdT.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: January 28, 2025
    Assignees: Illumina, Inc., Illumina Singapore Pte. Ltd.
    Inventors: Saurabh Rajendra Nirantar, Sergio Peisajovich, Eric Brustad
  • Patent number: 12212554
    Abstract: Flexible authentication technologies customized to particular tenants of a data center network can be implemented. For example, an administrator can specify a primary authentication server and specify at which data centers different applications are to be hosted for a given tenant. End users can be shielded from the complexities of implementing such configuration details. For example, single sign-on authentication can be implemented, even when applications are configured to be hosted in different data centers. Enterprise tenants can thus control where applications are hosted and enforce data containment scenarios without encumbering users with additional tasks. Collaboration and application-to-application authentication can be achieved.
    Type: Grant
    Filed: May 22, 2023
    Date of Patent: January 28, 2025
    Assignee: Illumina, Inc.
    Inventors: Milan Karangutkar, Prabhu Palanisamy, Satnam Alag
  • Patent number: 12209575
    Abstract: Actuation systems and methods are disclosed. An apparatus includes a system including a flow cell receptacle and a valve drive assembly including a shape memory alloy actuator including a pair of shape memory alloy wires and a flow cell disposable within the flow cell receptacle and having a membrane valve. The system actuates the membrane valve, via the shape memory alloy actuator, by causing a voltage to be applied to a first one of the shape memory alloy wires and the system not applying the voltage to a second one of the shape memory alloy wires.
    Type: Grant
    Filed: October 20, 2023
    Date of Patent: January 28, 2025
    Assignee: ILLUMINA, INC.
    Inventors: Reto Schoch, Xuance Zhou, Tarun Khurana, Chetanya Jain, Gregory Suematsu
  • Patent number: 12202950
    Abstract: Some embodiments described herein relate to a substrate with a surface comprising a silane or a silane derivative covalently attached to optionally substituted cycloalkene or optionally substituted heterocycloalkene for direct conjugation with a functionalized molecule of interest, such as a polymer, a hydrogel, an amino acid, a nucleoside, a nucleotide, a peptide, a polynucleotide, or a protein. In some embodiments, the silane or silane derivative contains optionally substituted norbornene or norbornene derivatives. Method for preparing a functionalized surface and the use in DNA sequencing and other diagnostic applications are also disclosed.
    Type: Grant
    Filed: March 27, 2023
    Date of Patent: January 21, 2025
    Assignee: Illumina, Inc.
    Inventors: Lorenzo Berti, Andrew A. Brown, Wayne N. George
  • Patent number: 12204086
    Abstract: A method is used to generate a distortion model for a structured illumination microscopy (SIM) optical system. A sliding window is moved in relation to a plurality of images to define a plurality of sub-tiles. Each sub-tile represents a portion of the corresponding image. Parameters are estimated for each sub-tiles. The parameters include two or more parameters selected from the group consisting of modulation, angle, spacing, phase offset, and phase deviation. A full width at half maximum (FWHM) value associated with each sub-tile is estimated. A distortion model is estimated, based at least in part on a combination of the estimated parameters and FWHM values stored in the predetermined format and an estimated center window parameter. A two-dimensional image may be generated, based at least in part on the estimated distortion model. The two-dimensional image may include representations indicating where distortions occur in the optical system.
    Type: Grant
    Filed: August 21, 2023
    Date of Patent: January 21, 2025
    Assignee: ILLUMINA, INC.
    Inventors: Robert Langlois, Bo Lu, Hongji Ren, Joseph Pinto, Simon Prince, Austin Corbett
  • Patent number: 12201985
    Abstract: Devices, systems, and methods for non-volatile storage include a well activation device operable to modify one or more wells from a plurality of wells of a flow cell to provide a set of readable wells. Readable wells are configured to allow exposure of a well to substances from nucleotide sequencing fluids, and prevent exposure to other substances and fluids, such as nucleotide synthesizing fluids. The well activation device may also modify wells to provide a set of writeable wells. This set of wells is configured to allow exposure to the nucleotide synthesizing fluids and substances; and prevent exposure to the nucleotide sequencing fluids and substances. There may also be provisions made for risk mitigation for data errors such as generating commands to write specified data to a nucleotide sequence associated with a particular location in a storage device, reading the nucleotide sequence and performing a comparison.
    Type: Grant
    Filed: January 31, 2023
    Date of Patent: January 21, 2025
    Assignee: Illumina, Inc.
    Inventors: Merek Siu, Ali Agah, Stanley Hong, Tarun Khurana, Aathavan Karunakaran, Craig Ciesla, Amirali Kia
  • Patent number: 12203076
    Abstract: The present invention relates to a method for introducing mutations into at least one target nucleic acid molecule comprising (a) providing at least one sample comprising at least one target nucleic acid molecule; and (b) amplifying the at least one target nucleic acid molecule using a low bias DNA polymerase. The present further relates to a use of a low bias DNA polymerase in a method for introducing mutations into one or more nucleic acid molecule(s), a group of sample tags, a method for designing the group of sample tags, a computer readable medium, and a method for preferentially amplifying target nucleic acid molecules.
    Type: Grant
    Filed: June 20, 2022
    Date of Patent: January 21, 2025
    Assignee: Illumina Singapore Pte. Ltd.
    Inventors: Leigh G. Monahan, Joyce To, Catherine Maree Burke, Michael Imelfort, Aaron Earl Darling
  • Patent number: 12195796
    Abstract: Embodiments of the present disclosure relate to cyclooctatetraene containing dyes and their uses as fluorescent labels. Also provided are composition containing cyclooctatetraene. The dyes and compositions may be used in various biological applications, such as nucleic acid sequencing.
    Type: Grant
    Filed: May 2, 2023
    Date of Patent: January 14, 2025
    Assignee: Illumina Cambridge Limited
    Inventors: Xiaolin Wu, Xiaohai Liu, Nikolai Nikolaevich Romanov, Antoine Francais, Patrick McCauley, Michael Callingham, Carole Anastasi
  • Patent number: 12195798
    Abstract: Presented are methods and compositions for obtaining sequence information from one or more individual cells. The methods are useful for obtaining sequence information for a single nucleotide sequence, and for multiplex generation of sequence information from one or more individual cells.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: January 14, 2025
    Assignees: Illumina, Inc., The Regents of the University of California
    Inventors: Jian-Bing Fan, Kun Zhang
  • Publication number: 20250011834
    Abstract: This application relates to functionalized magnetic particles and methods of using magnetic particles to generate amplicons. In some examples, a method of modifying a magnetic particle comprising a first functional group includes contacting the magnetic particle with a first molecule comprising a polymer coupled to second and third functional groups, wherein the first functional group reacts with the second functional group to form a bond via which the polymer is coupled to the magnetic particle. The method may include contacting the magnetic particle with a second molecule, the second molecule comprising an oligonucleotide coupled to a fourth functional group, wherein the third functional group reacts with the fourth functional group to form a bond via which the oligonucleotide is coupled to the magnetic particle.
    Type: Application
    Filed: June 25, 2024
    Publication date: January 9, 2025
    Applicant: Illumina, Inc.
    Inventors: Teodora Gal, Xavier von Hatten, Gianluca Artioli, Will Tovey, Nam Nguyen, Angelo La Rosa
  • Publication number: 20250011862
    Abstract: In some examples, a method for capturing and amplifying a polynucleotide includes capturing the polynucleotide at a particle comprising a first region and a second region. The first region may include a first moiety that captures the polynucleotide. The second region may include a plurality of amplification primers and have a surface area which is substantially larger than the surface area of the first portion. The method includes using the plurality of amplification primers to amplify the captured polynucleotide.
    Type: Application
    Filed: June 25, 2024
    Publication date: January 9, 2025
    Applicant: Illumina, Inc.
    Inventors: Sahngki Hong, Fei Shen, Lewis Kraft
  • Patent number: 12186746
    Abstract: A method for reducing sequencing by synthesis cycle time using a microfluidic device is provided. The microfluidic device comprises a flow cell having an inlet port, an outlet port, and a flow channel extending between the inlet port and the outlet port, wherein the flow channel receives an analyte of interest and one or more reagents for analyzing and detecting molecules. To aid in the acceleration of the reactions, the microfluidic device comprises a mixing device to increase the rates of diffusion of the reagents from the fluid bulk to an active surface of the flow cell. The mixing device comprises at least one of an electrothermal mixing device, an active mechanical mixing device, and a vibrational mixing device.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: January 7, 2025
    Assignee: ILLUMINA, INC.
    Inventors: Aathavan Karunakaran, Arnaud Rival, Ali Agah, Fabien Abeille, Steven Barnard, Craig Ciesla, Murali Venkatesan, Pargol Gheissari, Jennifer Wang, Dietrich Dehlinger
  • Patent number: 12188012
    Abstract: Provided herein are compositions that include nucleic acid fragments produced from double-stranded template nucleic acids, such as cell free DNA. The compositions can be used as positive or negative controls for quality of library preparation methods, calibration of an instrument such as a sequencing instrument, and/or a validation for a nucleic acid sequencing test. Also provided are methods for making the nucleic acid fragments.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: January 7, 2025
    Assignee: ILLUMINA, INC.
    Inventor: David Comstock
  • Patent number: 12188078
    Abstract: Presented are methods and compositions for preparing samples for amplification and sequencing. Particular embodiments relate to methods of preparing nucleic acid containing cellular samples for library amplification, wherein the methods include lysing cells of the sample to form a lysate, amplifying the nucleic acids from the lysed samples, wherein there is no purification of the nucleic acids from the lysate prior to the amplification, wherein amplifying comprises tagmentation, and sequencing the nucleic acids, wherein the sample is a blood sample or a formalin-fixed paraffin-embedded (FFPE) sample.
    Type: Grant
    Filed: September 15, 2021
    Date of Patent: January 7, 2025
    Assignee: Illumina Cambridge Limited
    Inventors: Louise Fraser, Paula Kokko-Gonzales, Andrew Slatter
  • Patent number: 12188848
    Abstract: A fluid detection system includes a wicking material to draw fluid away from a first location with space limitations and proximate to a fluid device or a fluid interface. The wicking material draws the fluid to a remote fluid indicator at a second location. Contact between fluid and the remote fluid indicator produces a detectable alteration to the remote fluid indicator, and a non-contact optical sensor detects the alteration.
    Type: Grant
    Filed: June 8, 2022
    Date of Patent: January 7, 2025
    Assignee: ILLUMINA, INC.
    Inventors: Gregory L. Holst, Jay Taylor
  • Patent number: 12188869
    Abstract: Light detection devices and related methods are provided. The devices may comprise a reaction structure for containing a reaction solution with a relatively high or low pH and a plurality of reaction sites that generate light emissions. The devices may comprise a device base comprising a plurality of light sensors, device circuitry coupled to the light sensors, and a plurality of light guides that block excitation light but permit the light emissions to pass to a light sensor. The device base may also include a shield layer extending about each light guide between each light guide and the device circuitry, and a protection layer that is chemically inert with respect to the reaction solution extending about each light guide between each light guide and the shield layer. The protection layer prevents reaction solution that passes through the reaction structure and the light guide from interacting with the device circuitry.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: January 7, 2025
    Assignee: ILLUMINA, INC.
    Inventors: Xiuyu Cai, Joseph Francis Pinto, Thomas A. Baker, Tracy Helen Fung
  • Patent number: D1059390
    Type: Grant
    Filed: September 25, 2022
    Date of Patent: January 28, 2025
    Assignee: Illumina, Inc.
    Inventors: Gordana Lamb, Nahida Badran, Jacob Dessau, Jack Godfrey Wood, Raymond Lawrence Oyung, John Tate Sager